Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Oct 2022	53	Global Markets Direct	ASDR-611917

Published: Oct 2022 - Pages : 53 - Publisher : Global Markets Direct - Report code : ASDR-611917

Boehringer Ingelheim International GmbH
Genervon Biopharmaceuticals LLC
Helixmith Co Ltd
Regulaxis SAS
SIFI SpA
Stem Cell Medicine Ltd
Twinpigbiolab Co Ltd

Insulin biosimilars Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

This report can be of interest as well:

Insulin biosimilars Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Published: April, 2024 | Report code: ASDR-663292